Stock·NASDAQ·Basic Materials
ASP Isotopes Inc. (ASPI)
- Market cap
- $328.08M
- Dividend yield
- 0.00%
- Street target
- $13.00median of 3 analysts
- 52-week range
- $2.03 $11.22
The short version
Where ASPI stands today, in four lines, and what CleaRank Financial AI makes of it.
ASPI at a glance
ASP Isotopes Inc. (ASPI): Sell, 35/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($3.40 and $5.08).
- Earnings ASPI beat estimates in 1 of its last 6 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $13.2M and bought $62K over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
ASP Isotopes Inc. (ASPI) carries a CleaRank rating of Sell and a model score of 35/100.
The analysts' outlook is the strongest support for the score: all 3 analysts rate the stock a buy, and the median target is 507.5% above the price. The trend is the heaviest drag. The price is 57.89% below the 200-day average and 37.10% below the 50-day average, and the 50-day average is 33.05% below the 200-day. The 50-day average is $3.40 and the 200-day is $5.08. Over the past year, the price dropped 80.63%.
Only on CleaRank
Figures we compute ourselves from ASPI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $2.14 is 37.1% below the 50-day simple moving average of $3.40.Price above its 200-day average ›
The price is 57.9% below the 200-day simple moving average of $5.08.50-day average above the 200-day ›
The 50-day average ($3.40) is 33.0% below the 200-day average ($5.08), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $2.03 and $11.22.
ASPI share price
Pick a period: each tab shows how far ASPI has moved over it, to the last close.
Today's trading
Where ASPI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 10.98 is 161.5% above the sector median of 4.2.Profitable over the last 12 months ›
Net income over the last 12 months was $-151.6M on revenue of $30.9M, a net margin of -491.5%.Beat estimates in most recent reports ›
ASPI beat the EPS estimate in 1 of its last 6 reports.
Key statistics
The headline figures for ASPI.
As of October 17, 2026, ASPI trades at $2.14, with a market value of $328.08M and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of ASPI's valuation, growth and risks.
ASPI has no meaningful P/E, because the company lost money over the last 12 months, which is why that measure is not meaningful here. On sales, the P/S of 10.98 is 161.4% above the sector median of 4.2. To put the size in context, the company has a market value of $328.1M, and its trailing earnings come to -$1.49 a share.
ASPI is not yet profitable. Its net margin is -491.48% and its operating margin is -667.48%. Revenue rose 327.60% in the latest year, a pace 308.6 percentage points faster than the 19.0% sector median for Basic Materials. Return on equity stands at -90.35%, below the sector median of 17.9%, and debt-to-equity is 0.98.
In its most recent report, on August 14, 2026, ASPI posted EPS of -$0.25 versus the -$0.31 analysts expected, topping the estimate by 19.35%. The market reacted the other way, with the stock falling 5.85% the following session.
ASPI beat estimates in 1 of the last 6 reports, but the stock still fell in the first session after that beat. Analysts currently forecast EPS of -$0.56 for this fiscal year and -$0.7067 for the next.
ASPI's average daily move is 4.74%, so the stock can swing sharply from day to day. The downtrend is a risk in its own right while the price stays under both moving averages. The price is 80.93% below the 52-week high of $11.22. Insiders sold $13.2M of stock over the last 18 months and bought $62K. Sales can be planned ahead or made to cover tax on vesting shares, so they carry less weight than open-market purchases would.
ASPI against the Basic Materials sector
How ASPI compares with the median Basic Materials stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, ASPI trades at 10.98x, +161% versus the sector average of 4.20x.
Return vs XLB: Since May 6, 2025, ASPI has lost 61.0% against a gain of 21.7% for XLB.
Performance against XLB
ASPI and the Basic Materials sector fund over the same days.
Revenue and earnings
How much ASPI sells, and how much of it becomes profit.
Revenue growth: Revenue grew 475.5% in FY2025 to $23.8M, from $4.1M a year earlier.
Profit margin: The net margin was -670.2% in FY2025, up from -782.4% the year before.
Loss-making: ASPI lost $160M in FY2025.
Earnings reality check
Did ASPI beat what analysts expected, and how did the stock react?
Earnings record: ASPI beat the analyst estimate in 1 of the last 6 quarters.
Market reaction: The stock fell in the first session after 1 of those 1 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 14, 2026after close | -$0.31 | -$0.25 | +19.35% | -5.85% | -6.32% |
| Apr 10, 2026after close | -$0.14 | -$0.41 | -192.86% | +12.95% | +19.87% |
| Nov 19, 2025after close | -$0.10 | -$0.15 | -50.00% | -11.40% | -21.07% |
| May 20, 2025after close | -$0.10 | -$0.12 | -20.00% | +10.86% | +11.14% |
| Mar 30, 2025after close | -$0.09 | -$0.13 | -44.44% | +2.77% | -2.56% |
| Nov 19, 2024after close | -$0.09 | -$0.12 | -33.33% | -1.38% | -19.31% |
As of October 17, 2026, ASPI has beaten the analyst EPS estimate in 1 of its last 6 reported quarters and fell in the first trading session after it; its latest report, on August 14, 2026, came in 19.35% above the estimate and the stock moved -5.85% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 27.7, in oversold territory.RSI above 50 ›
An RSI of 27.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of ASPI
The score, the reasoning behind it, and what could move the price next.
ASPI is trading at $2.14, below both of its main moving averages. The price sits 37.10% below the 50-day average of $3.40 and 57.89% below the 200-day average of $5.08. It is at 1% of its 52-week range, which leaves it 5.42% above the 52-week low of $2.03. The 50-day average is 33.05% below the 200-day, a gap that backs up the weak trend rather than cutting against it.
On momentum, the 14-day RSI reads 27.7, in oversold territory, with the MACD line negative. Every period on the chart shows a loss, with the price down 44.77% over the past three months, 60.15% over the past six months and 80.63% over the past year.
Earnings beat ›
The August 14, 2026 report beat the EPS estimate by 19.35%, and the share price fell 5.85% in the first session after it.
Source: Earnings report, August 14, 2026
No risks flagged.
- The two closest levels to watch are the 20-day EMA at $2.69, which sits above the price, and the 52-week low at $2.03, which sits below it.
- The 14-day RSI is 27.7, in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- ASPI's share price fell 5.85% in the first session after the August 14, 2026 report. In the last 6 reports, the company beat estimates once.
ASPI remains in a downtrend while it trades below both its 50-day average of $3.40 and its 200-day average of $5.08. A close back above the 50-day average would mark the first step toward a repair. The nearest hurdle overhead is the 20-day EMA at $2.69.
ASPI's next level below the price is the 52-week low of $2.03. The RSI is in the oversold zone, so a recovery above that oversold line would be the first sign that selling pressure is easing.
Technical indicators
Momentum and trend for ASPI, from its daily closes.
As of October 17, 2026, with ASPI at $2.14, its 14-day RSI is 27.7 (oversold territory), its 50-day simple moving average is $3.40 and its 200-day is $5.08.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ASPI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, ASPI's 1-year correlation of daily returns is +0.39 with S&P 500 (SPY), +0.43 with Nasdaq 100 (QQQ), +0.35 with Bitcoin (BTC) and +0.26 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/2Most analysts rate it a buy ›
3 of 3 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $13.00 is 507.5% above the price.
ASPI Wall Street View
12-month price targets
The price, $2.14, sits below every analyst's target.
Ratings
As of October 17, 2026, 3 Wall Street analysts cover ASPI: 3 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $11.00 to $15.00, with a median of $13.00, 507.5% above the price of $2.14.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ASPI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
ASPI moves about 4.7% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ASPI tends to move, against the market and on its own.
The long record
ASPI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 4.74% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 87.6%, from November 2022 to May 2023, regained by February 2024.Most 1-year holds ended higher ›
78% of 1-year holding periods in the last 4 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in November 2022 is now worth $8,014.98, against $20,364 in the S&P 500 (SPY).
ASPI Drawdowns & Recovery
As of October 17, 2026, ASPI's worst peak-to-trough fall over the last 4 years with dividends reinvested was -87.6% (November 2022 to May 2023); it regained that peak by February 2024, 9 months after the low, and 78% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ASPI in November 2022 is worth now, against the same amount in the S&P 500.
Against the market: ASPI trailed the S&P 500 over this period: $8,014.98 against $20,364.
A $10,000 investment in ASPI in November 2022 would be worth about $8,015 today with dividends reinvested, compared with about $20,364 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ASPI, and which have not.
Strongest month, October: an average of +46.11%, up in 2 of 3 years.
Weakest month, March: an average of -18.63%, up in 1 of 4 years.
This month, October: has averaged +46.11%, up in 2 of 3 years. Past seasonality does not repeat on schedule.
Over the last 4 years, ASPI's strongest calendar month has been October (average +46.11%, up in 2 of 3 years) and its weakest March (average -18.63%, up in 1 of 4 years).
Average return for each calendar month over the last 4 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ASPI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ASPI today could grow to about $11,780 by 2036 in the base case, with a 90th-percentile outcome near $89,371 and a 10th-percentile outcome around $1,553. Projections are statistical simulations, not guarantees.
ASPI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $2.28 for ASPI by 2030 in the base case, from $2.14 today (1.1x over 4 years). The 10th-percentile path ends near $0.6343. These are outcomes of a Monte Carlo simulation run on ASPI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $1.15 | $2.18 | $4.13 | |
| 2028 | $0.8935 | $2.21 | $5.47 | |
| 2029 | $0.7409 | $2.25 | $6.82 | |
| 2030 | $0.6343 | $2.28 | $8.23 | |
| 2031 | $0.5542 | $2.32 | $9.73 |
Method: a lognormal simulation of ASPI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
ASPI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $62K on the open market and sold $13.2M.
As of October 17, 2026, ASPI insiders reported 28 open-market sales worth $13.2M and 2 open-market purchases worth $62K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Robert John Andrew Ryan
Director
|
Buy | 15.0K | $40.2K |
| Sep 28, 2026 | Robert John Andrew Ryan
Director
|
Buy | 8.0K | $21.6K |
| Sep 8, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 8.4K | $36.2K |
| Sep 4, 2026 | Paul Elliot Mann
Chief Executive Officer
|
Sell | 251.3K | $999.2K |
| Sep 2, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 25.0K | $97.6K |
| Sep 2, 2026 | Donald George Ainscow
General Counsel
|
Sell | 23.7K | $92.1K |
| Jul 1, 2026 | Heather Kiessling
Chief Financial Officer
|
Sell | 23.1K | $145.2K |
| Jun 30, 2026 | Todd Wider
Director
|
Sell | 100.0K | $618.5K |
| Jun 30, 2026 | Donald George Ainscow
General Counsel
|
Sell | 100.0K | $614.0K |
| Jun 30, 2026 | Michael Gorley
Director
|
Sell | 30.0K | $188.1K |
| Jun 8, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 8.4K | $59.1K |
| Jun 3, 2026 | Paul Elliot Mann
Chief Executive Officer
|
Sell | 251.3K | $2.0M |
| May 28, 2026 | Donald George Ainscow
General Counsel
|
Grant | 400.0K | - |
| May 28, 2026 | Robert Ainscow
Chief Operating Officer
|
Grant | 800.0K | - |
| May 28, 2026 | Heather Kiessling
Chief Financial Officer
|
Grant | 840.0K | - |
| May 28, 2026 | Paul Elliot Mann
Chief Executive Officer
|
Grant | 2.2M | - |
| Apr 16, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 22.5K | $117.1K |
| Apr 16, 2026 | Duncan Moore
Director
|
Sell | 11.6K | $60.6K |
| Apr 15, 2026 | Heather Kiessling
Chief Financial Officer
|
Sell | 23.1K | $126.7K |
| Mar 6, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 25.0K | $112.8K |
| Mar 6, 2026 | Robert Ainscow
Chief Operating Officer
|
Sell | 8.4K | $45.9K |
| Mar 2, 2026 | Paul Elliot Mann
Officer
|
Sell | 162.2K | $881.5K |
| Dec 18, 2025 | Heather Kiessling
Chief Financial Officer
|
Sell | 80.0K | $463.8K |
| Dec 18, 2025 | Michael Gorley
Director
|
Grant | 36.5K | - |
| Dec 18, 2025 | Ralph L. Hunter Jr
Director
|
Grant | 36.5K | - |
| Dec 18, 2025 | Duncan Moore
Director
|
Grant | 62.0K | - |
| Dec 18, 2025 | Robert John Andrew Ryan
Director
|
Grant | 36.5K | - |
| Dec 18, 2025 | Todd Wider
Director
|
Grant | 36.5K | - |
| Dec 8, 2025 | Robert Ainscow
Chief Executive Officer
|
Sell | 8.4K | $52.3K |
| Dec 1, 2025 | Paul Elliot Mann
Officer and Director
|
Sell | 162.2K | $932.9K |
| Nov 25, 2025 | Paul Elliot Mann
Officer and Director
|
Sell | 162.5K | $1.1M |
| Nov 25, 2025 | Robert Ainscow
Chief Executive Officer
|
Sell | 25.0K | $144.2K |
| Nov 17, 2025 | Robert Ainscow
Chief Executive Officer
|
Sell | 67.5K | $506.7K |
| Nov 12, 2025 | Todd Wider
Director
|
Grant | 25.5K | - |
| Oct 14, 2025 | Robert Ainscow
Chief Executive Officer
|
Sell | 22.5K | $306.0K |
| Sep 30, 2025 | Michael Gorley
Director
|
Sell | 64.0K | $624.2K |
| Sep 15, 2025 | Todd Wider
Director
|
Sell | 74.1K | $648.8K |
| Sep 12, 2025 | Todd Wider
Director
|
Option | 96.0K | $192.0K |
| Sep 9, 2025 | Paul Elliot Mann
Chief Executive Officer
|
Sell | 162.2K | $1.4M |
| Sep 9, 2025 | Robert Ainscow
Chief Operating Officer
|
Option | 297.0K | $331.5K |
| Sep 9, 2025 | Paul Elliot Mann
Chief Executive Officer
|
Option | 1.2M | $2.4M |
| Sep 8, 2025 | Robert Ainscow
Chief Operating Officer
|
Sell | 8.4K | $71.9K |
| Sep 5, 2025 | Ralph L. Hunter Jr
Director
|
Grant | 10.5K | - |
| Aug 29, 2025 | Duncan Moore
Director
|
Sell | 75.0K | $696.2K |
| Aug 1, 2025 | Donald George Ainscow
General Counsel
|
Grant | 400.0K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.